Table 3.
Logistic regression analysis of baseline variables associated to mortality risk, readmission and functional decline at 3 months (adjusted for age and sex)
| Mortality | Readmission | Functional decline | Cognitive impairment | Depressive symptoms | |
|---|---|---|---|---|---|
| Charlson index ≥ 3 | 3.84 (1.17–12.59) | 1.81 (0.80–4.10) | 2.10 (0.96–4.58) | 1.00 (0.44–2.27) | 1.13 (0.56–2.32) |
| CFS* | 7.27 (0.86–61.71) | 3.07 (0.96–9.78) | 0.93 (0.38–2.23) | 1.59 (0.63–4.03) | 1.12 (0.52–2.39) |
| 1–4 | 1 | 1 | 1 | 1 | 1 |
| 5–6 | 3 (0.25–36.06) | 1.72 (0.44–6.75) | 0.87 (0.31–2.45) | 1.23 (0.41–3.68) | 1.62 (0.66–4) |
| 7–9 | 10.56 (1.21–72.51) | 4.16 (1.25–13.83) | 0.96 (0.37–2.50) | 1.87 (0.69–5.06) | 0.86 (0.38–2) |
| Dementia pre-admission | 2.03 (0.64–6.42) | 2.64 (1.16–5.97) | 1.50 (0.71–3.17) | 1.27 (0.59–2.70) | 0.99 (0.51–1.92) |
| BI† < 40 at discharge | 5.08 (1.53–16.91) | 4.53 (1.96–10.49) | 1.58 (0.71–3.50) | 2.15 (0.97–4.77) | 0.94 (0.46–1.95) |
| Hospitalization FD | 1.32 (0.39–4.51) | 1.53 (0.65–3.60) | 24.57 (9.24–65.39) | 2.32 (1.03–5.25) | 0.23 (0.09–0.54) |
| Albumin < 30 g/L | 1.4 (0.40–4.86) | 3.35 (1.42–7.92) | 2.56 (1.24–5.86) | 0.45 (0.16–1.29) | 0.49 (0.22–1.09) |
| Length of hospitalization | 1.02 (0.96–1.09) | 1.01 (0.97–1.06) | 1.04 (0.99–1.08) | 1.00 (0.96–1.05) | 1.00 (0.97–1.04) |
| Readmission | 5.88 (1.20–12.53) | 3.20 (1.33–7.68) |
Bold value indicates statistical significance
*CFS Clinical Frailty Scale; †BI Barthel Index